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ABSTRACT
Background: Differences in arrhythmogenic substrate may explain the variable 
efficacy of implantable cardioverter-defibrillators (ICDs) in primary sudden cardiac 
death prevention over time after myocardial infarction (MI). Speckle-tracking 
echocardiography allows the assessment left ventricular (LV) dyssynchrony, which 
may reflect the electromechanical heterogeneity of myocardial tissue. The aim of 
the present study was to evaluate the relationship among LV dyssynchrony, age of 
MI, and their association with the risk for ventricular tachycardia (VT) after MI.
Methods: A total of 206 patients (median age 67 years; 87% men) with prior 
MIs (median MI age 6.2 years; interquartile range 0.66–15 years) who underwent 
programmed electrical stimulation, speckle-tracking echocardiography, and ICD 
implantation were retrospectively evaluated. LV dyssynchrony was defined as 
the standard deviation of time to peak longitudinal systolic strain values using 
speckle-tracking strain echocardiography. LV scar burden was evaluated by the 
percentage of segments exhibiting scar (defined as an absolute longitudinal 
strain of magnitude <4.5%). Patients were followed up for the occurrence of first 
monomorphic VT requiring ICD therapy (antitachycardia pacing or shock) for a 
median of 24 months.
Results: In total, 75 individuals experienced the primary end point of 
monomorphic VT. LV dyssynchrony was independently associated with the 
occurrence of VT at follow-up (hazard ratio per 10-msec increase 1.12, 95% 
confidence interval 1.07–1.18, p<0.001), together with nonrevascularization of 
the infarct-related artery and VT inducibility. Patients with older (>180 months) 
MIs had a higher likelihood of VT inducibility (88% vs 63%, p=0.003) and greater 
scar burden (14.7 ± 15.8% vs. 10.7 ± 11.4%, p=0.03) compared with patients with 
recent (<8 months) MIs.
Conclusions: LV dyssynchrony is independently associated with the occurrence of 
VT after MI.
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INTRODUCTION
Sudden cardiac death (SCD), which is attributed mostly to ventricular tachycardia (VT), 
accounts for approximately 50% of all deaths in patients with coronary heart disease.1 
The interaction between the arrhythmogenic substrate and several factors that influence 
electrical stability (e.g., autonomic tone, myocardial ischemia) is crucial in the genesis of 
VT. The use of an implantable cardioverter-defibrillator (ICD) in patients with left ventricular 
(LV) ejection fractions (LVEFs) ≤35% within 40 days after myocardial infarction (MI) has not 
demonstrated a survival advantage,2 despite the known survival benefit of ICD use in other 
patients with LVEFs ≤35%.3 Moreover, a progressive increase in mortality risk late after MI 
has been described among ICD recipients.4 Differences in arrhythmogenic substrate early 
and late after MI may explain those findings and underscore the importance of substrate 
characterization to determine the mechanisms of SCD. A key feature of the myocardial 
substrate after MI is slow conduction through inhomogeneous scar tissue.5,6 Collagen 
deposition in particular within the infarct border zone may occur over years after the index 
MI, resulting in progressive separation of viable myocardial fibers and thus more dispersed 
electrical impulse propagation through the left ventricle.7
 The emergence of speckle-tracking echocardiography has permitted more refined 
evaluation of LV myocardial function and tissue characteristics after MI.8 This technique 
allows the assessment of the temporal heterogeneity of segmental myocardial deformation, 
which may reflect the electromechanical heterogeneity of myocardial tissue.9 With the use 
of speckle-tracking echocardiography, in the present evaluation we investigated (1) the 
relationship between MI age and LV mechanical and electrophysiologic characteristics and 
(2) the association between LV dyssynchrony and risk for VT in ICD recipients after MI.
METHODS
Patient Population
The population comprised patients with prior MIs who underwent programmed electrical 
stimulation (PES) followed by ICD implantation at the Leiden University Medical Center. 
All patients underwent transthoracic echocardiography before or <6 months after 
ICD implantation. For patients undergoing biventricular ICD (CRT-D) implantation, 
echocardiography was performed after CRT-D placement, with the pacemaker on to ensure 
representation of current physiology. Exclusion criteria were an uncertain date of MI, the 
presence of reversible ischemia, pacemaker dependence before ICD implantation, and the 
occurrence of VT between ICD insertion and echocardiography.
 All clinical, electrophysiologic, and echocardiographic data were collected in the 
departmental cardiology information system (EPD-Vision; Leiden University Medical Center, 
Leiden, The Netherlands) and retrospectively analyzed.
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Echocardiography
Patients were imaged in the left lateral decubitus position using a commercially available 
system equipped with 3.5-MHz and 5S transducers (Vivid 7 and E9; GE Vingmed Ultrasound 
AS, Horten, Norway). Two-dimensional grayscale, color, pulsed-wave, and continuous-wave 
Doppler data were acquired in the parasternal and apical views. Images were recorded 
digitally in cine-loop format and analyzed offline with EchoPAC version 11.0.0 (GE Vingmed 
Ultrasound AS). Left atrial volume and LV end-systolic and end-diastolic volumes were 
measured from the apical two- and four-chamber views and indexed to body surface 
area. LVEF was calculated using the biplane Simpson’s technique.9 Mitral regurgitation 
severity was graded as none/mild or moderate/severe by incorporating a number of 
echocardiographic indicators, including regurgitant jet vena contracta width, proximal 
flow convergence, effective regurgitant orifice area measured with the proximal isovelocity 
surface area method, color jet area, continuous-wave Doppler spectral profile intensity, 
E-wave velocity, and pulmonary venous flow reversal.10
Strain Analysis
Evaluation of LV myocardial deformation was performed with speckle-tracking 
echocardiography.11 These measurements were performed by two investigators blinded 
to patient outcomes using the Q-analysis application on an EchoPAC version 11.0.0 
workstation. In each of the three apical views, the LV myocardium was manually contoured, 
and the contours were adjusted to achieve optimal tracking of all myocardial segments 
over the cardiac cycle. The software automatically generated curves of strain as a function 
of time (Figure 1). Using an 18-segment model derived from the three apical views, 
segmental peak systolic longitudinal myocardial strain and time to peak longitudinal strain 
were recorded. Longitudinal strain in normally contracting myocardium is by convention 
negative, but for simplicity, we report absolute strain values, denoted as |strain|. Thus, 
poorer myocardial contraction is reflected by a lower |strain| value. Myocardial segments 
were classified as having transmural scar if the longitudinal |strain| value was <4.5%. This 
threshold has been previously validated against late gadolinium enhancement cardiac 
magnetic resonance imaging.12
 LV scar burden was evaluated by the percentage of LV segments exhibiting 
transmural scar. LV dyssynchrony was defined as the standard deviation of values of time to 
peak longitudinal systolic strain in this 18-segment model (Figure 1).11 Global longitudinal 
strain (GLS) was measured as the mean of peak |strain| values from each myocardial 
segment.11
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Figure 1. Speckle-tracking echocardiographic strain. Representative examples of speckle-tracking 
strain curves from two patients with LVEFs of 55%. Patient A demonstrated greater heterogeneity in 
time to peak segmental strain compared with patient B. LVEF = left ventricular ejection fraction.
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PES
PES was performed according to current guidelines.13 In brief, patients were studied in 
a fasting, nonsedated state and after the discontinuation of antiarrhythmic medications 
(except for amiodarone) for five half-lives.14 PES included up to three drive-cycle lengths 
(600, 500, and 400 msec) with up to three ventricular extrastimuli and burst pacing from 
the right ventricular apex and right ventricular outflow tract. Positive response to PES was 
defined as the reproducible induction of sustained monomorphic VT lasting >30 sec or 
requiring termination because of hemodynamic compromise.
Outcomes
VT was identified from examination of ICD electrograms stored after device therapy 
administration. The appropriateness of this therapy and the nature of the ventricular 
arrhythmia (to distinguish monomorphic VT from polymorphic VT or ventricular fibrillation) 
were adjudicated by an electrophysiologist who was blinded to patients’ clinical 
characteristics. The primary end point was the occurrence of first monomorphic VT 
requiring device therapy (antitachycardia pacing or shock) after ICD implantation. Patients 
were censored at the date of most recent outpatient appointment unless the primary end 
point occurred earlier. In addition, the occurrence and date of occurrence of the following 
significant competing risks were recorded if they took place after ICD implantation and 
before VT occurrence: polymorphic VT, ventricular fibrillation, upgrade to CRT-D, VT 
ablation, revascularization for acute coronary syndrome, or LV reconstructive surgery.
Statistical Analysis
Patients were divided into quartiles according to age of MI (i.e., time from index MI to 
ICD insertion). Nominally, these groups were described as very old for the quartile with 
the oldest MI age and recent for the quartile with the youngest MI age. Categorical data 
are summarized as frequencies and percentages and were compared using c2 or Fisher 
exact tests as appropriate. Continuous variables are presented as mean ± SD or median 
(interquartile range [IQR]) and were compared between groups using analysis of variance 
or Kruskal-Wallis tests for normally and non-normally distributed data, respectively. Post 
hoc testing for pairwise comparisons was performed with Bonferroni adjustment. The 
relationship between scar percentage and MI age was evaluated by generalized linear 
modeling. Because of the highly skewed distribution and wide variance relative to the mean 
of scar percentage, a negative binomial probability distribution was assumed.
 For time-to-event (monomorphic VT) analysis, a competing-risks strategy was 
adopted. A competing risk is an event whose occurrence alters or precludes the occurrence 
of an event of interest (monomorphic VT). When competing risks are present, competing-
risks regression is regarded as an appropriate approach to time-to-event analysis.15,16 In 
the present analysis, the following events occurring before the occurrence of the primary 
end point of monomorphic VT were treated as competing risks: ventricular fibrillation, 
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polymorphic VT, ICD upgrade, coronary revascularization, and LV reconstructive surgery.17-19 
The covariates that were examined as potential predictors of monomorphic VT were 
chosen on the basis of clinical relevance or demonstrated prognostic value after MI. These 
covariates included.
• Clinical factors (age, gender, hypertension, diabetes mellitus, infarct territory, New 
York Heart Association functional class III or IV, creatinine clearance, ICD indication 
[secondary vs primary], revascularization of the infarct-related artery, and age of MI),
• QRS duration on electrocardiography,
• Conventional echocardiographic parameters (LV end-systolic volume index, left atrial 
volume index, and LVEF),
• Speckle-tracking echocardiographic parameters that formed the focus of the present 
study (GLS, LV scar burden, and LV dyssynchrony), and
• VT inducibility on PES.
 Those covariates achieving p-values <0.20 at the univariate level were evaluated 
in a multivariate competing-risks analysis that was performed with backward elimination. 
Differences in the cumulative incidence of monomorphic VT between groups were 
assessed.20
 The incremental benefit of novel predictors of monomorphic VT was evaluated first 
by the Wald test comparing the model with the novel predictor and the model without the 
novel predictor. Second, the incremental value of novel risk predictors was evaluated using 
the integrated discrimination improvement index; a value significantly greater than zero is 
indicative of additive discriminatory value of the new risk predictor of interest.21
 In 10 randomly selected individuals, echocardiographic strain measurements were 
repeated by a second investigator to determine interobserver variability. The interrater 
agreement for classification of scar was evaluated by the k statistic and the interobserver 
variability for LV dyssynchrony and GLS by the intraclass correlation coefficient for a two-
way random-effects model for consistency of agreement and by the absolute difference 
between observers divided by the mean of the repeated observations expressed as a 
percentage.
 For all tests, a two-sided a value of 0.05 was adopted to determine statistical 
significance. Analysis was performed using Stata version 13.1 (StataCorp LP, College 
Station, TX).
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RESULTS
Patient Characteristics
A total of 206 patients (median age 67 years; IQR 57–73 years; 180 [87%] men) meeting 
the inclusion criteria were studied. These comprised 171 ICD recipients (83%) and 35 
CRT-D recipients (17%). The median MI age was 6.2 years (IQR 0.66–15 years). Patient 
characteristics are displayed as a function of age of MI in Table 1. Individuals with very 
old MIs (MI age in the highest quartile, >180 months prior) were of more advanced age 
(p<0.001), had worse renal function (p=0.007), and had longer QRS durations (p<0.001). 
They also had less frequent revascularization of the infarct-related artery (p<0.001), and 
the infarct-related artery more often subtended the inferoposterior LV segments (p=0.03) 
compared with those with more recent MIs. These patients more often received ICDs as 
secondary prevention (p=0.002).
Echocardiographic and Electrophysiologic Characteristics
Table 2 summarizes the echocardiographic and electrophysiologic characteristics of the 
patient population. Patients with very old MIs exhibited greater scar burden (14.7 ± 15.8% 
vs. 10.7 ± 11.4%, p=0.03) and more left atrial dilatation (36 mL/m2 [IQR 27–50 mL/m2] vs. 
28 mL/m2 [IQR 23–35 mL/m2], p=0.005) compared with patients with recent MIs (MI age in 
the lowest quartile, <8 months). Patients with very old MIs showed a higher likelihood of VT 
inducibility compared with those with recent MIs (88% vs. 63%, p=0.003). To examine the 
possibility that the increase in scar burden with infarct age was related to the confounding 
effects of changing practice over time with regard to revascularization of the culprit artery, 
we also adjusted for revascularization status in the generalized linear model of infarct age. 
This adjusted analysis did not significantly affect the positive relationship between scar 
burden and infarct age (coefficient 0.15, 95% confidence interval [CI] 0.013–0.28, p=0.03). 
We undertook two post hoc sensitivity analyses in which a scarred segment was defined as 
one with |strain| <4% and <5%, respectively. The adjusted coefficients for the relationship 
between scar burden and infarct age were 0.18 (95% CI 0.043 to 0.32, p=0.01) and 0.11 
(95% CI –0.022 to 0.25, p=0.10), respectively.
Outcomes
The median follow-up time after ICD implantation was 24 months (IQR 7.8–47 months). 
In total, 75 individuals experienced the primary end point of monomorphic VT, and 18 
patients had competing events. VT ablation was performed in six patients (3%) after ICD 
implantation: in four individuals, this occurred after a primary end point event, whereas 
in the remaining two, the date of ablation was treated as the study exit date. In a further 
eight patients, subsequent ICD upgrade to CRT-D resulted in study exit at the time of 
the upgrade. LV reconstructive surgery was performed in four individuals (2%) after ICD 
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Quartile 1 
(<8 mo)
Quartile 2 
(8–75 mo)
 Quartile 3 
(75–180 mo)
Quartile 4 
(>180 mo)
p
(n=52) (n=52) (n=51) (n=51)
Age (y) 63 (51–71) 62 (53–67) 68 (58–73) 74 (67–76)*,†,‡ <0.001
Men 47 (90%) 42 (81%) 43 (84%) 48 (94%) 0.20
Hypertension 25 (48%) 16 (31%) 17 (33%) 19 (37%) 0.30
Diabetes mellitus 13 (25%) 6 (12%) 8 (16%) 8 (16%) 0.30
Smoking 0.20
   Never 20 (38%) 24 (46%) 19 (37%) 27 (53%)
   Previous 11 (21%) 18 (35%) 20 (39%) 15 (29%)
   Current 21 (41%) 10 (19%) 12 (24%) 9 (18%)
Infarct territory 0.03
   Inferior/posterior 17 (33%) 15 (29%) 16 (31%) 28 (55%)
   Anterior 35 (67%) 37 (71%) 35 (69%) 23 (45%)
NYHA class 0.04
   I or II 48 (92%) 37 (71%) 38 (75%) 40 (78%)
   III or IV 4 (8%) 15 (29%) 13 (25%) 11 (22%)
Secondary prevention ICD 34 (65%) 21 (40%) 29 (57%) 39 (76%) 0.002
Revascularized infarct-related 
artery
21 (40%) 24 (46%) 14 (27%) 1 (2%) <0.001
AF/atrial flutter 5 (10%) 13 (25%) 13 (25%) 11 (22%) 0.10
Creatinine clearance (mL/min) 78 (56–103) 74 (58–98) 75 (59–94) 62 (48–77)*,†,‡ 0.007
QRS duration (msec) 107 ± 26 109 ± 23 130 ± 26 138 ± 35*,† <0.001
Table 1. Patient characteristics
AF = atrial fibrillation; ICD = implantable cardioverter-defibrillator; NYHA = New York Heart 
Association.
Data are expressed as median (IQR), number (percentage), or mean ± SD. The threshold p-value for 
pairwise comparisons between groups was p<0.004, by Bonferroni adjustment.
* p<0.004 compared with quartile 1.
† p<0.004 compared with quartile 2.
‡ p<0.004 compared with quartile 3.
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Table 2. Echocardiographic and electrophysiologic characteristics
GLS = global longitudinal strain; LAVI = left atrial volume index; LV = left ventricular; LVEDVI = left 
ventricular end-diastolic volume index; LVEF = left ventricular ejection fraction; LVESVI = left ventricular 
end-systolic volume index; MR = mitral regurgitation; PVT = polymorphic ventricular tachycardia; VF = 
ventricular fibrillation; VT = ventricular tachycardia.
Data are expressed as median (IQR), number (percentage), or mean ± SD.
* p<0.004 compared with quartile 1.
† p<0.004 compared with quartile 2.
Quartile 1 
(<8 mo)
Quartile 2 
(8–75 mo)
 Quartile 3 
(75–180 mo)
Quartile 4 
(>180 mo)
p
(n=52) (n=52) (n=51) (n=51)
LVESVI (mL/m2) 41 (33 to 52) 49 (34 to 66) 49 (33 to 64) 47 (35 to 65) 0.20
LVEDVI (mL/m2) 69 (57 to 85) 80 (65 to 97) 79 (59 to 100) 77 (56 to 97) 0.30
LAVI (mL/m2) 28 (23 to 35) 27 (21 to 37) 32 (22 to 40) 36 (27 to 50)*, † 0.005
Moderate/severe MR 1 (2%) 5 (10%) 4 (9%) 6 (12%) 0.20
LVEF (%) 41 ± 9.9 40 ± 13 38 ± 11 36 ± 8.2 0.10
GLS (%) 10.9           
(9.81 to 14.3)
12.8               
(10.4 to 14.9)
–10.1               
(8.25 to 13.6)
–11.7              
(8.58 to 13.4)
0.10
LV percentage scar (%) 10.7 ± 11.4 12.1 ± 15.1 13.1 ± 12.9 14.7 ± 15.8* 0.03
Patients with ≥1 dyskine- 
tic myocardial segment
7 (13%) 12 (23%) 11 (25%) 10 (20%) 0.60
LV dyssynchrony (msec) 82 ± 29 81 ± 34 97 ± 40 91 ± 43 0.09
VT inducible 33 (63%) 30 (58%) 36 (71%) 45 (88%) 0.003
VF/PVT inducible 8 (15%) 18 (35%) 8 (16%) 4 (8%) 0.006
implantation: in two cases, this occurred after a primary end point event, whereas in the 
other two, the date of surgery was used as the study exit date.
Time-to-Monomorphic VT Analysis
Table 3 contains the competing-risks regression for predictors of time to monomorphic 
VT. Those factors achieving univariate p-values <0.20 included age, creatinine clearance, 
QRS duration, revascularization of the infarct-related artery, age of MI, LV end-systolic 
volume index, LVEF, GLS, LV scar burden, LV dyssynchrony, and VT inducibility on PES. 
On multivariate analysis, nonrevascularization of the infarct-related artery (p=0.02), longer 
QRS duration (p=0.001), greater LV dyssynchrony (p<0.001), and lower GLS (p=0.02) 
were independently associated with later development of VT. Each 10-msec increment in 
LV dyssynchrony was associated with a 12% increase in the risk for monomorphic VT. In 
addition, the evaluation of LV dyssynchrony conferred incremental predictive value to an 
infarct-related artery nonrevascularization, QRS duration, and GLS, as demonstrated by the 
Wald test (c2 = 17, p=0.001) and an integrated discrimination improvement index of 0.027 
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Table 3. Multiple competing-risks regression for the occurrence of VT
GLS = global longitudinal strain; ICD = implantable cardioverter-defibrillator; LAVI = left atrial volume 
index; LV = left ventricular; LVEF = left ventricular ejection fraction; LVESVI = left ventricular end-systolic 
volume index; MI = myocardial infarction; NYHA = New York Heart Association; SHR = subdistribution 
hazard ratio; VT = ventricular tachycardia.
Univariate Multivariate
SHR (95% CI) p SHR (95% CI) p
Age 1.02 (1.00–1.05) 0.03 0.995 (0.963–1.03) 0.90
Female gender 0.83 (0.43–1.6) 0.60
Hypertension 0.81 (0.50–1.3) 0.40
Diabetes mellitus 1.0 (0.58–1.9) 0.90
NYHA class III or IV 1.1 (0.63–1.9) 0.70
Creatinine clearance 0.988 (0.981–0.996) 0.002 0.998 (0.989–1.00) 0.70
QRS duration 1.012 (1.006–1.019) <0.001 1.011 (1.004–1.019) 0.001
Anterior infarct-related territory 0.94 (0.59–1.5) 0.80
Secondary prevention ICD 1.4 (0.86–2.4) 0.20
Revascularized infarct-related 
artery
0.42 (0.23–0.79) 0.007 0.49 (0.26–0.91) 0.02
Time from index MI 1.002 (1.001–1.004) 0.005 0.9999 (0.9971–1.003) 1.00
LVESVI 1.007 (1.000–1.013) 0.05 0.9920 (0.9843–0.9998) 0.05
LAVI 1.00 (0.989–1.02) 0.70
LVEF 0.97 (0.95–0.99) 0.008 0.99 (0.96–1.0) 0.60
GLS, % reduction in magnitude 1.08 (1.02–1.15) 0.01 1.08 (1.02 –1.16) 0.02
LV percentage scar 1.03 (1.01–1.04) 0.001 0.997 (0.969–1.03) 0.80
LV dyssynchrony, 10-msec         
increase
1.14 (1.09–1.19) <0.001 1.12 (1.06–1.18) <0.001
VT inducible 2.9 (1.6–5.5) 0.001 1.8 (0.90–3.5) 0.10
(p=0.001). These indicate that the measurement of LV dyssynchrony in addition to PES 
provided superior prediction of subsequent VT.
 The cohort was dichotomized on the basis of the median value of LV dyssynchrony 
into those exhibiting LV dyssynchrony ≤90 and >90 msec. Those with LV dyssynchrony >90 
msec had a significantly greater incidence of monomorphic VT compared with those with 
less LV dyssynchrony (p<0.001) (Figure 2).
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Interobserver Variability
For segmental scar classification, the k statistic for interrater agreement was 0.72, indicating 
substantial concordance between observers. For GLS measurement, the average intraclass 
correlation coefficient was 0.94 (95% CI 0.74–0.98), while for LV dyssynchrony, it was 0.96 
(95% CI 0.84–0.99). The difference between observers expressed as a percentage of the 
mean of their measurements was 0.022% for GLS and 4.5% for LV dyssynchrony.
DISCUSSION
The main findings of this study are that (1) greater LV dyssynchrony is associated with an 
increased risk for monomorphic VT, independent of MI age and revascularization of the 
infarct-related vessel, and (2) older MI is associated with greater LV scar burden than more 
recent infarction, independent of whether the culprit artery was revascularized.
Myocardial Infarction Age, Myocardial Scar, and VT
LV remodeling after MI is a complex time-related process involving ultrastructural and 
histologic myocardial changes that may be reflected in macroscopic alterations in LV 
geometry and function.22-24 Specifically, edema and inflammation early after MI are 
superseded by collagen deposition and myocardial scar formation late after MI.23 This 
process of scar formation in the infarct zone, as well as myocardial collagen deposition 
in remote areas, continues months to years after the indexMI.23 This evolution is manifest 
by LV dilatation and dysfunction.25-27 However, there is scant evidence on very late scar 
Figure 2. LV dyssynchrony and VT risk. Cumulative incidence of the primary end point of monomorphic 
VT that required ICD therapy, as a function of LV dyssynchrony. The p-value was obtained by the 
approach of Pepe and Mori.20 ICD = implantable cardioverter-defibrillator; LV = left ventricular; VT = 
ventricular tachycardia.
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progression after MI. In the present study, a trend toward worse LV systolic function was 
indeed observed in advancing quartiles of MI age. In fact, a more marked and significant 
increase in LV scar burden was demonstrated in advancing quartiles of MI age. This was 
accompanied by increasing left atrial volume with increasing MI age, a finding that provides 
some face validity to our observation of increasing LV scar with MI age. These findings add 
to the existing research by characterization of myocardial substrate very late after MI.
 VT, an important cause of SCD after MI, has been associated with an increased 
scar burden on electroanatomic mapping6 and using late gadolinium enhanced cardiac 
magnetic resonance imaging.28 Data from the Multicenter Automatic Defibrillator 
Implantation Trial II study showed a direct association between mortality risk and increasing 
time from MI; the presence of extensive scar after MI (as reflected by an LVEF ≤30%) was 
an independent determinant of lethal ventricular arrhythmias.4 The present study has 
delivered consistent findings by demonstrating that at the univariate level, scar burden 
by speckle-tracking echocardiography is associated with the risk for monomorphic VT. 
However, myocardial scar burden is only one of the characteristics of the arrhythmogenic 
substrate. Other factors, such as how scar influences electrical impulse propagation and 
electromechanical coupling, may be important in the development of reentrant VT.
LV Dyssynchrony and VT
Collagen deposition and remodeling occur after MI principally in the infarcted zone but also 
in the peri-infarct and remote regions. The slowed and heterogeneous electrical impulse 
propagation associated with scar tissue favors the development of clinical VT by permitting 
reentry. In the present evaluation, we hypothesized that the mechanical consequences of 
MI might be related to the subsequent risk for VT. LV dyssynchrony was measured using 
speckle-tracking strain echocardiography as an index of the heterogeneity of timing of 
segmental myocardial contraction. The potential slowing of global LV electromechanical 
coupling, which could result from both scar in the infarct zone and collagen deposition in 
the peri-infarct and remote zones, would result in less coordinated LV contraction and a 
higher LV dyssynchrony index. We found that greater LV dyssynchrony was associated with 
an elevated risk for subsequent VT. There are several possible explanations for this finding. 
First, LV dyssynchrony may promote ongoing ventricular remodeling, particularly in the 
infarct or peri-infarct zones that form the LV substrate for VT. Second, LV dyssynchrony may 
also be an indicator of scar and the functional consequences of scar that promote VT.
 There is growing recognition of the importance of myocardial substrate 
characteristics in the pathogenesis of VT after MI.29 This may be particularly true for 
monomorphic VT, which, in contrast to polymorphic VT and ventricular fibrillation, is 
mediated by fixed scar and heterogeneous scar conduction.6 In the present study, 
although LV scar burden was associated with the occurrence of VT during follow-up, LV 
dyssynchrony was independently associated with VT. Thus, LV dyssynchrony as a marker of 
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the heterogeneity of LV activation seems able to characterize the substrate that predisposes 
to VT.
 The results of the present evaluation are consistent with those of a previous study 
showing that LV dyssynchrony was greater in post-MI patients with recurrent VT.9 The 
present study also demonstrates that LV dyssynchrony provides complementary information 
to QRS duration in the identification of patients who will experience recurrent VT. Both 
QRS duration and wider LV dyssynchrony, in addition to nonrevascularization of the infarct-
related artery and GLS, were shown in the present study to be independently associated 
with the risk for subsequent VT.
Limitations
Echocardiography was performed at a single time point, so the temporal evolution of LV 
remodeling is inferred rather than proved by serial measurements in each individual. This 
research was undertaken at a tertiary center among patients referred for electrophysiologic 
assessment and consideration for ICD placement. Referral bias is therefore likely, which 
may have implications for the generalizability of the study findings. Our findings must be 
externally validated to confirm their clinical importance.
CONCLUSIONS
LV dyssynchrony, which results from myocardial scar tissue interspersed with viable 
myocytes, is independently associated with the subsequent occurrence of VT. Older MI 
exhibits greater scar burden, and more LV dyssynchrony independently of whether the 
culprit artery was revascularized or not. These observations may help understanding of the 
survival benefit seen with ICD implantation later after MI, compared with earlier.
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